Skip to main content
Premium Trial:

Request an Annual Quote

Blockbuster Drugs...So Last Century?

Is the blockbuster model dead? Turna Ray, who writes GT’s sister publication Pharmacogenomics Reporter, posited that this might be the case for big pharma, which hopes to one day sell therapies more aligned with personalized treatment. There seems to be growing consensus: Chris Anderson, editor of Wired and author of the 2006 book, The Long Tail, blogged a few days ago about a New England Journal of Medicine article that ponders the potential demise of the one-size-fits-all blockbuster.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.